Eisai Malaysia Launches Dayvigo to Combat Rising Insomnia Incidence
In Malaysia, insomnia is on the rise, affecting millions of people’s quality of life and daytime functioning. To combat this issue, Eisai (Malaysia) Sdn Bhd recently launched Dayvigo, a new treatment for insomnia, in conjunction with World Sleep Day.
The launch of Dayvigo aims to provide Malaysians with an effective treatment option for their sleepless nights. Eisai Malaysia hopes to raise awareness of sleep health and prevent the emergence of other chronic diseases that can result from sleep deprivation.
“We are thrilled to bring Dayvigo into the market, providing an additional treatment option for people with insomnia,” said Kam Ai Teng, Managing Director of Eisai Malaysia. “After thorough research, our team of researchers and scientists have worked tirelessly to develop a product that is effective to help individuals who struggle with insomnia get the restful sleep they need to improve their overall health, and we are confident that Dayvigo will bring a positive change to their lives.”
[the_ad id=”10542″]
Dayvigo is a Dual Orexin Receptor Antagonist (DORA) treatment that has been rigorously tested in clinical trials. It is highly effective in helping individuals fall asleep quickly, with minimal impacts on their next morning alertness or next day function. Dayvigo is a novel class of treatment that facilitates individuals to sleep by suppressing wakefulness.
“At Eisai Malaysia, we take great pride in contributing positively to a person’s well-being,” said Kam. “Our commitment goes beyond merely innovating treatments but also ensuring that society gains the equal opportunity to benefit from our contribution. This World Sleep Day, we are determined to bring the awareness of insomnia to the forefront of Malaysians’ health education, and we will continue seeking alternatives and work towards increasing people’s access to treatment for diverse health conditions so that everyone can lead a fulfilling life.”
The launch witnessed the participation of Prof Ng Chong Guan, Consultant Psychiatrist and Treasurer of Malaysian Psychiatric Association and Dr Hazli Zakaria, Founder of Alaminda Healthcare Berhad who shared the platform to exchange thoughts and discourse addressing the key concerns surrounding insomnia.
[the_ad id=”10542″]
“Insomnia is a severe health issue that affects millions of people worldwide,” said Kam. “We fail to realise the severity of insomnia until it’s too late, and people now need to know that it can arise at different phases of the sleep cycle and induce daytime impairments such as fatigue, daytime sleepiness, mood changes, and other symptoms.”
The incidence of insomnia is rising, and appropriate education, awareness initiatives, and therapies must be provided to individuals needing them. With the launch of Dayvigo, Eisai Malaysia is single-minded to treat insomnia to improve Malaysians’ quality of life while preventing other chronic diseases that may emerge as a result of sleep deprivation.
[the_ad id=”10542″]
